コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tely and died by 4 months of age with severe hypoxemia.
2 he venular endothelium to the same extent as hypoxemia.
3 nal endothelial cell injury) associated with hypoxemia.
4 e control group received HFOV for refractory hypoxemia.
5 ble coughing, urticaria, edema, wheezing and hypoxemia.
6 copy following hypoventilation, may decrease hypoxemia.
7 in patients with severe ARDS and refractory hypoxemia.
8 e development of life-threatening refractory hypoxemia.
9 ked by impaired gas exchange and significant hypoxemia.
10 esterol levels, compared to subjects without hypoxemia.
11 me oxygen values, have only mild to moderate hypoxemia.
12 dyspnea and oxygen for short-term relief of hypoxemia.
13 ems accurate, especially for moderate-severe hypoxemia.
14 and body mass index influenced ictal-related hypoxemia.
15 management of silent infarcts and nocturnal hypoxemia.
16 ation in critically ill patients with severe hypoxemia.
17 o are oxygen non-responsive with intractable hypoxemia.
18 ntially aggravating systemic hypercarbia and hypoxemia.
19 pulmonary disease (COPD) and severe resting hypoxemia.
20 BCs is impaired in diseases characterized by hypoxemia.
21 e lung injury, patchy alveolar flooding, and hypoxemia.
22 ion and pulmonary arterial hypertension with hypoxemia.
23 t-to-left shunt pathophysiology and systemic hypoxemia.
24 and concerns over hypercapnia, acidosis, and hypoxemia.
25 ake at anaerobic threshold, and 54 developed hypoxemia.
26 ce of acute lung injury and resultant severe hypoxemia.
27 of infant human and rabbit hearts to chronic hypoxemia.
28 aryngoscopy (apneic oxygenation) may prevent hypoxemia.
29 d for oxygen and is especially vulnerable to hypoxemia.
30 cardia did not alter the prognostic value of hypoxemia.
31 mes were similarly increased after prolonged hypoxemia.
32 to safety process measures, and frequency of hypoxemia.
33 dent sympathetic activation and/or degree of hypoxemia.
34 ochemical indicators of vitamin A status and hypoxemia.
35 atients is frequently associated with severe hypoxemia.
36 fetus as growth restriction and progressive hypoxemia.
37 la may offer an alternative in patients with hypoxemia.
38 including the management of HPS with severe hypoxemia.
39 are similar to those of SCD mice but without hypoxemia.
40 ts was associated with a lower prevalence of hypoxemia (10.1% vs. 17.4%, p = .022) and a lower preval
41 in more than one patient included transient hypoxemia (19%), radiation pneumonitis (11%), and fatigu
43 in the presence of respiratory distress and hypoxemia (2C), use of physical examination therapeutic
44 subjects with severe COPD and only moderate hypoxemia; (3) efficacy of nocturnal O(2) supplementatio
45 e likely than those with normal CXRs to have hypoxemia (45% vs 26%), crackles (69% vs 62%), tachypnea
46 transfusion, higher fluid balance, obesity, hypoxemia, acidosis, tobacco use, emergent hematoma evac
47 Randomized clinical trial of patients with hypoxemia after cardiac surgery at a single ICU in Brazi
50 ere 67% and 52% (P = .02), and for recurrent hypoxemia after oxygen supplementation were 38% and 18%
55 t the immediate implementation of permissive hypoxemia and a comprehensive evaluation of its value in
56 ficant correlations noted between CYP2E1 and hypoxemia and beta-OH butyrate suggest that these factor
58 n is influenced by the severity of nocturnal hypoxemia and comorbid obesity has not been determined.
72 lps detect extracardiac pathology leading to hypoxemia and may be used to guide fluid resuscitation a
74 ease are at risk for respiratory failure and hypoxemia and need to be screened for hepatopulmonary sy
75 is associated with a decreased prevalence of hypoxemia and reduced rate of procedure-related complica
78 l life support can lead to rapid reversal of hypoxemia and shock; however, it can also result in vary
80 he severity of lung injury and the degree of hypoxemia and/or the effects of ventilator settings on g
82 a, and hypomagnesemia; 14 patients (52%) had hypoxemia, and 9 (33%) had oliguria, of whom 5 had anuri
84 cular outflow tract obstruction, unexplained hypoxemia, and aortic dissection, among others, can all
87 o mobilization were hemodynamic instability, hypoxemia, and dependency on venovenous extracorporeal m
89 rs appear to be exaggerated polycythemia and hypoxemia, and lower and sluggish CBF compared to CMS pa
92 1 had lower respiratory tract disease (LRD), hypoxemia, and prolonged viral shedding compared with se
97 Obstructive sleep apnea (OSA) and nocturnal hypoxemia are associated with chronic kidney disease and
98 ce rate of ICU-acquired infection and severe hypoxemia are expected outcomes from RBC transfusion tha
99 determine the effect of postoperative IS on hypoxemia, arterial oxygen saturation (Sao2) level, and
100 ntrol of arterial oxygenation and permissive hypoxemia as candidate management strategies in hypoxemi
106 rtality, ICU-acquired infections, and severe hypoxemia) at day 30, we used marginal structural models
107 yndrome in acute liver failure are scant and hypoxemia being a commonly encountered systemic complica
108 nt differences in frequency of postoperative hypoxemia between the control and test groups were found
109 horacentesis may be complicated by transient hypoxemia, bleeding, patient discomfort, reexpansion pul
111 rtality, which was accompanied by attenuated hypoxemia, cardiopulmonary dysfunction, and pulmonary ed
112 e the clearance of Abeta from the brain, and hypoxemia characteristic of sleep-disordered breathing i
113 gue muscles are coactivated in conditions of hypoxemia comparable to that experienced by adults with
115 oxygenation and reduced prevalence of severe hypoxemia compared with nonrebreathing bag reservoir fac
116 se to AngII was less in patients with severe hypoxemia compared with those with moderate hypoxemia (P
117 agic telangiectasia: iron deficiency impairs hypoxemia compensations by restricting erythropoiesis an
118 During hemorrhagic shock, the occurrence of hypoxemia considerably alters villous intestinal perfusi
121 case identification that included the milder hypoxemia criterion for ALI would yield incidence number
124 ectin-1:mIgG1 and Dectin-1:mIgG2a Fc reduced hypoxemia despite minimal effects on fungal burden in th
125 atic sickle cell disease exacerbated by mild hypoxemia, despite a newborn-screening diagnosis of sick
128 that trigger white matter injury, transient hypoxemia disrupted SPN arborization and functional matu
129 rs in sepsis patients with severe refractory hypoxemia due to ARDS (2C); prone positioning in sepsis-
130 ve sleep apnea is primarily characterized by hypoxemia due to frequent apneic episodes and fragmentat
131 of advanced liver disease, characterized by hypoxemia due to intrapulmonary vascular dilatations.
133 cted at limiting the duration or severity of hypoxemia during brain development may mitigate disturba
136 to providing a reasonable safeguard against hypoxemia during laryngoscopy and endotracheal intubatio
138 = 0.03) and subjects with any two events of hypoxemia during sedation, maintenance or recovery were
140 ge in body mass index, severity of nocturnal hypoxemia, E/E', and sex were independently associated w
141 hyperalgesia in volunteers, while nocturnal hypoxemia enhanced morphine analgesic potency in childre
150 ; 95% CI, 2.33-3.28; p < 0.01) and of severe hypoxemia (hazard ratio, 1.29; 95% CI, 1.14-1.47; p < 0.
152 Obstructive sleep apnea causes intermittent hypoxemia, hemodynamic fluctuations, and sleep fragmenta
153 ressure level of 40 mm Hg during 30 minutes, hypoxemia-hemorrhagic shock group in which PaO2 was decr
154 opped in a synergistic manner (69% +/- 3% in hypoxemia-hemorrhagic shock group vs 94 +/- 2 in hemorrh
155 igations in animals suggest that concomitant hypoxemia hinders resuscitation attempts, and that epine
157 in total lung capacity, resulting in chronic hypoxemia, hypercapnia, and increased erythropoietin syn
158 e high risk for death associated with severe hypoxemia, hypercapnia, or both not responding to maximi
159 e high risk for death associated with severe hypoxemia, hypercapnia, or both not responding to maximi
160 ologic (Glasgow Coma Scale) and respiratory (hypoxemia, hypercapnia, or nursing requirements for comp
161 physiologically detrimental conditions (e.g. hypoxemia, hypercarbia, acidosis, hypothermia, hypervole
164 in adults, the initial severity of arterial hypoxemia in children correlates well with mortality.
165 fetuses enhanced the vasodilator response to hypoxemia in circulations in which blood flow is known t
169 on (PAH) is commonly associated with chronic hypoxemia in disorders such as chronic obstructive pulmo
170 ve signals all noninvasively-measured during hypoxemia in healthy volunteers include four signals mea
171 ere selected that explored the physiology of hypoxemia in healthy volunteers or critically ill patien
172 corporeal membrane oxygenation) to alleviate hypoxemia in patients unable to maintain reasonable oxyg
173 oes not appear to lead to increased rates of hypoxemia in patients undergoing ambulatory upper endosc
174 etermine the incidence and severity of ictal hypoxemia in patients with localization-related epilepsy
175 med on these 25 subjects to examine cerebral hypoxemia in specific regions (periventricular white mat
177 ol metabolism in erythrocytes, and implicate hypoxemia in the pathobiology of erythrocyte-based vascu
179 esponses to stress and diminished arousal to hypoxemia, in part because of failures in genetically de
180 entrations; each 10% increase in duration of hypoxemia increased BNP by 9.6% (95% confidence interval
181 ociation of HD with severe SDB and nocturnal hypoxemia independent of age, BMI, and the higher preval
182 cally derived apnea-hypopnea index (AHI) and hypoxemia index (percent of sleep time with oxyhemoglobi
183 using the apnea-hypopnea index (AHI) and the hypoxemia index (percent sleep time below 90% oxyhemoglo
184 number of apneas/hypopneas per hour) and the hypoxemia index (percentage of time below 90% O2 saturat
185 s significantly associated with both AHI and hypoxemia index after adjustment for age, sex, ethnicity
188 For categories of increasing severity of the hypoxemia index, the corresponding relative hazards were
190 inority of patients with ARDS and refractory hypoxemia, institution of these therapies may be conside
195 to many pathophysiological causes; avoiding hypoxemia is an important objective during neonatal anes
201 are consistent with an injury model in which hypoxemia is exacerbated by endotoxin-mediated failure o
205 clude species that tolerate acute or chronic hypoxemia like deep-diving mammals and high-altitude inh
206 d in reduced carotid arterial O2 saturation (hypoxemia), lung pathology, pulmonary edema, reduced lun
208 fits of attempting to fully reverse arterial hypoxemia may be outweighed by the harms associated with
211 Acute interventions specifically targeting hypoxemia, metabolic acidosis, hyperglycemia, and cardio
212 lusive categories of ARDS based on degree of hypoxemia: mild (200 mm Hg < PaO2/FIO2 </= 300 mm Hg)
215 ratory distress syndrome use some measure of hypoxemia, neither the Berlin definition nor recently pr
217 rotective factor of the occurrence of severe hypoxemia (odds ratio, 0.146; 95% CI, 0.01-0.90; p = 0.0
218 -venous extracorporeal membrane oxygenation, hypoxemia (odds ratio, 1.68; 95% CI, 1.09-2.57) and mode
220 gy to withstand episodes of subsequent acute hypoxemia of the type that may occur during labor and de
222 fetuses were exposed to 2 episodes of acute hypoxemia, on separate days, during infusion with either
223 preterm infants may experience intermittent hypoxemia or bradycardia for many weeks after birth.
225 transient worsening of mismatch by episodic hypoxemia or hypotension also reproducibly triggers PIDs
226 n of the uterine vasculature during maternal hypoxemia or hypotension makes this goal a significant c
228 anagement of isolated fast breathing without hypoxemia or other clinical signs of illness in term you
229 exposing children to recurrent intermittent hypoxemia or oxidative stress, may amplify the adverse e
230 tatus (mean nocturnal SaO2, >/=90% [moderate hypoxemia] or <90% [severe hypoxemia]) and 13 obese cont
233 , however, depending on baseline severity of hypoxemia (P = 0.0003), with harm increasing with PaO2/F
234 hypoxemia compared with those with moderate hypoxemia (P = 0.001) and obese control subjects after 3
235 n patients with COPD who have severe resting hypoxemia (Pao(2) </=55 mm Hg or Spo(2) </=88%) (Grade:
238 ated patients admitted to the ICU with acute hypoxemia (PaO2/FIO2 </= 300) and bilateral opacities.
239 44 [54%] vs 135 [72%]; p=0.006), more severe hypoxemia (PaO2/FIO2: 165+/-73 mm Hg vs 199+/-79 mm Hg;
241 bariatric surgery, the severity of nocturnal hypoxemia predicted Angptl4 levels in subcutaneous adipo
244 and critical care medicine, including apnea, hypoxemia, pulmonary hypertension, asthma, cystic fibros
248 emental approach to the management of severe hypoxemia requires implementation of the strategies revi
249 unit patients) were characterized by severe hypoxemia (requiring high levels of inspired oxygen and
253 opulmonary resuscitation results in profound hypoxemia, respiratory acidosis, and significantly worse
254 eatening situations associated with profound hypoxemia, respiratory acidosis, or hemodynamic compromi
255 markers of obstructive sleep apnea severity (hypoxemia, respiratory disturbances, and sleep fragmenta
256 ertrophy and thickening were associated with hypoxemia, respiratory disturbances, and sleep fragmenta
257 on to lower respiratory tract disease (LRD), hypoxemia, respiratory failure, and overall and influenz
258 After WLS, there was rapid onset of profound hypoxemia resulting in acute pulmonary hypertension and
259 s of overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and mortality.
261 bance index [RDI] > 15 h(-1)) with nocturnal hypoxemia (SaO2 < 90% for >12% of the night) were studie
262 not demonstrate any effect on postoperative hypoxemia, Sao2 level, or postoperative pulmonary compli
263 The primary end point was the occurrence of hypoxemia; secondary end points were the occurrences of
264 e presence of terminal illness, tachypnea or hypoxemia, septic shock, platelet count <150,000 cells/m
268 25 h(-1)), stratified according to nocturnal hypoxemia status (mean nocturnal SaO2, >/=90% [moderate
269 management) were similar in mild and severe hypoxemia subsets as defined by PaO(2)/Fio(2) ratios.
270 ients with critical illness characterized by hypoxemia such as acute respiratory distress syndrome.
271 of severe respiratory failure and refractory hypoxemia such as that seen in patients with severe acut
277 epatopulmonary syndrome leads to progressive hypoxemia through diffuse vasodilatation of the pulmonar
278 ral vasoconstriction during subsequent acute hypoxemia through elevated nitric oxide (NO) activity.
282 nsing is essential to avoid life-threatening hypoxemia via hypoxic pulmonary vasoconstriction (HPV) w
284 rease in Kupffer cell phagocytosis following hypoxemia was also prevented by Wortmannin or YC-1 treat
291 ected myocardial infarction who did not have hypoxemia was not found to reduce 1-year all-cause morta
294 ent in patients treated with efaproxiral was hypoxemia, which was reversible and effectively managed
295 ivation and accumulation in the lung lead to hypoxemia, widespread tissue damage, and respiratory fai
300 n to function as an early warning system for hypoxemia, would decrease hypoxemia during endoscopy.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。